Emergency medicine physician-researchers at the University of Cincinnati have shown that a targeted quality improvement campaign can safely reduce unnecessary head and cervical spine (neck) computed tomography (CT) scans in… read more.
People with atrial fibrillation have signs of the condition in the retinas of their eyes that can be detected as early as four years before diagnosis, finds a… read more.
An artificial intelligence model that analyzes women’s past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that… read more.
Royal Philips and Imricor Medical Systems announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration combines Philips’ 1.5T MRI platform… read more.
In the 1970s, psychiatric diagnoses were marked by considerable uncertainty and disagreement. Since then, organisations such as the American Psychiatric Association and the World Health Organization (WHO) have… read more.
Men already at risk genetically for the most common form of hair loss have a 7 percent added risk of losing their hair if they use drugs like… read more.
A deep-learning tool developed to analyze sinus CT scans may provide a more sensitive way to detect treatment-related changes in patients with chronic rhinosinusitis with nasal polyps, according… read more.
GE HealthCare recently achieved CE Mark for Photonova Spectra, an advanced photon-counting computed tomography (PCCT) system with the company’s proprietary Deep Silicon detector technology. The regulatory milestone expands… read more.
Quest Diagnostics announced two new developments for its Quest AD-Detect portfolio of blood-based biomarker tests for Alzheimer’s disease, with the goal of broadening access to quality blood tests… read more.
BioMarin Pharmaceutical Inc. announced that it has entered into binding terms with Ascendis Pharma A/S, resolving the patent and ancillary disputes pending globally, including before the U.S. International… read more.
Immedica announces that Japan’s Ministry of Health, Labor and Welfare (MHLW) has granted Orphan Drug Designation (ODD) to pegzilarginase for the treatment of arginase 1 deficiency (ARG1-D), a… read more.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in collaboration with an international partnership of researchers, has, for the first… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
